Activity of Colistin in Combination with Meropenem, Tigecycline, Fosfomycin, Fusidic Acid, Rifampin or Sulbactam against Extensively Drug-Resistant Acinetobacter baumannii in a Murine Thigh-Infection Model

Colistin and Fusidic Acid, a Novel Potent Synergistic Combination for Treatment of Multidrug-Resistant Acinetobacter baumannii Infections

(2015) Lynette M. Phee et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Excess Mortality Associated With Colistin-Tigecycline Compared With Colistin-Carbapenem Combination Therapy for Extensively Drug-Resistant Acinetobacter baumannii Bacteremia

(2015) Aristine Cheng et al.   CRITICAL CARE MEDICINE

In vitro synergy of polymyxins with other antibiotics for Acinetobacter baumannii: A systematic review and meta-analysis

(2015) Wentao Ni et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

In vivo activity of daptomycin/colistin combination therapy in a Galleria mellonella model of Acinetobacter baumannii infection

(2015) Haifei Yang et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Efficacy of Sulbactam and Its Combination with Imipenem, Colistin and Tigecycline in an Experimental Model of Carbapenem-Resistant Acinetobacter baumannii Sepsis

(2014) Gokcen Dinc et al.   CHEMOTHERAPY

Colistin/daptomycin: an unconventional antimicrobial combination synergistic in vitro against multidrug-resistant Acinetobacter baumannii

(2014) Irene Galani et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Combination therapy for carbapenem-resistant Gram-negative bacteria

(2014) M. Paul et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Systematic Review and Meta-Analysis ofIn VitroSynergy of Polymyxins and Carbapenems

(2013) Oren Zusman et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Activity of Tigecycline in Combination with Colistin, Meropenem, Rifampin, or Gentamicin against KPC-Producing Enterobacteriaceae in a Murine Thigh Infection Model

(2013) George Michail et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Synergistic Activity of Colistin and Rifampin Combination against Multidrug-Resistant Acinetobacter baumannii in anIn VitroPharmacokinetic/Pharmacodynamic Model

(2013) Hee Ji Lee et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Colistin and Rifampicin Compared With Colistin Alone for the Treatment of Serious Infections Due to Extensively Drug-Resistant Acinetobacter baumannii: A Multicenter, Randomized Clinical Trial

(2013) Emanuele Durante-Mangoni et al.   CLINICAL INFECTIOUS DISEASES

Is there really no benefit to combination therapy with colistin?

(2013) Jason M Pogue et al.   Expert Review of Anti-Infective Therapy

In vivo efficacy of telavancin/colistin combination therapy in a Galleria mellonella model of Acinetobacter baumannii infection

(2013) Michael Hornsey et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Activity of fosfomycin alone or combined with cefoxitin in vitro and in vivo in a murine model of urinary tract infection due to Escherichia coli harbouring CTX-M-15-type extended-spectrum β-lactamase

(2013) Agnès Lefort et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Therapeutic options forAcinetobacter baumanniiinfections: an update

(2012) Jordi Vila et al.   EXPERT OPINION ON PHARMACOTHERAPY

Colistin: an update on the antibiotic of the 21st century

(2012) Silpak Biswas et al.   Expert Review of Anti-Infective Therapy

Efficacy of tigecycline/colistin combination in a pneumonia model caused by extensively drug-resistant Acinetobacter baumannii

(2012) Esmeray Mutlu Yilmaz et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

In VivoEfficacy of Glycopeptide-Colistin Combination Therapies in aGalleria mellonellaModel ofAcinetobacter baumanniiInfection

(2011) M. Hornsey et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance

(2011) A.-P. Magiorakos et al.   CLINICAL MICROBIOLOGY AND INFECTION

In vitro activity of teicoplanin combined with colistin versus multidrug-resistant strains of Acinetobacter baumannii

(2011) D. W. Wareham et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Efficacy of Rifampin and Its Combinations with Imipenem, Sulbactam, and Colistin in Experimental Models of Infection Caused by Imipenem-Resistant Acinetobacter baumannii

(2010) M. E. Pachon-Ibanez et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Potent Synergy and Sustained Bactericidal Activity of a Vancomycin-Colistin Combination versus Multidrug-Resistant Strains of Acinetobacter baumannii

(2010) N. C. Gordon et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Influence of Genospecies of Acinetobacter baumannii Complex on Clinical Outcomes of Patients with Acinetobacter Bacteremia

(2010) Y.-C. Chuang et al.   CLINICAL INFECTIOUS DISEASES

Ineffectiveness of Tigecycline against Persistent Borrelia burgdorferi

(2009) S. W. Barthold et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Antimicrobial Resistance:Acinetobacter baumannii:Epidemiology, Antimicrobial Resistance, and Treatment Options

(2008) Lisa L. Maragakis et al.   CLINICAL INFECTIOUS DISEASES

Efficacy of monotherapy and combined antibiotic therapy for carbapenem-resistant Acinetobacter baumannii pneumonia in an immunosuppressed mouse model

(2008) Joon Young Song et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

In vivo efficacy and pharmacokinetics of tomopenem (CS-023), a novel carbapenem, against Pseudomonas aeruginosa in a murine chronic respiratory tract infection model

(2008) Y. Morinaga et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY